Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
King JB, Berchie RO, Derington CG, Marcum ZA, Scharfstein DO, Greene TH, Herrick JS, Jacobs JA, Zheutlin AR, Bress AP, Cohen JB. King JB, et al. Among authors: bress ap. J Am Heart Assoc. 2023 Sep 5;12(17):e030311. doi: 10.1161/JAHA.123.030311. Epub 2023 Aug 30. J Am Heart Assoc. 2023. PMID: 37646208 Free PMC article.
Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial.
Derington CG, Bress AP, Moran AE, Weintraub WS, Herrick JS, Cushman WC, Kronish IM, Stults B, Shimbo D, Muntner P, Greene T, Bates JT, Chang TI, Katz LA, Rehman SU, Roumie CL, Tamariz L, King JB. Derington CG, et al. Hypertension. 2023 Mar;80(3):590-597. doi: 10.1161/HYPERTENSIONAHA.122.20373. Epub 2022 Dec 15. Hypertension. 2023. PMID: 36519451 Free PMC article. Clinical Trial.
Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial.
King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, Cushman WC, Bress AP. King JB, et al. Among authors: bress ap. Hypertension. 2023 Aug;80(8):1749-1758. doi: 10.1161/HYPERTENSIONAHA.123.21132. Epub 2023 Jun 8. Hypertension. 2023. PMID: 37288570 Free PMC article. Clinical Trial.
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L, Shen J, Ying J, Derington CG, Cohen JB, Marcum ZA, Herrick JS, King JB, Cheung AK, Williamson JD, Pajewski NM, Bryan N, Supiano M, Sonnen J, Weintraub WS, Greene TH, Bress AP. Ghazi L, et al. Among authors: bress ap. JAMA Netw Open. 2023 May 1;6(5):e2314443. doi: 10.1001/jamanetworkopen.2023.14443. JAMA Netw Open. 2023. PMID: 37204788 Free PMC article. Clinical Trial.
Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT.
Zheutlin AR, Addo DK, Jacobs JA, Derington CG, Herrick JS, Greene T, Stulberg EL, Berlowitz DR, Williamson JD, Pajewski NM, Supiano MA, Bress AP. Zheutlin AR, et al. Among authors: bress ap. Hypertension. 2023 Jul;80(7):1484-1493. doi: 10.1161/HYPERTENSIONAHA.123.21323. Epub 2023 May 11. Hypertension. 2023. PMID: 37165900 Free PMC article. Clinical Trial.
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.
Derington CG, Bress AP, Berchie RO, Herrick JS, Shen J, Ying J, Greene T, Tajeu GS, Sakhuja S, Ruiz-Negrón N, Zhang Y, Howard G, Levitan EB, Muntner P, Safford MM, Whelton PK, Weintraub WS, Moran AE, Bellows BK. Derington CG, et al. Am J Hypertens. 2023 Aug 5;36(9):498-508. doi: 10.1093/ajh/hpad047. Am J Hypertens. 2023. PMID: 37378472 Free PMC article.
169 results